PDUFA VII Talks Begin With Similar Goals For Industry, US FDA

Both sides want enhancements to deal with growth in cell and gene therapy, as well as work on regulatory decision tools and finance issues.

US FDA entrance sign
PDUFA VII talks began 15 September and likely will last several months. • Source: File photo

More from User Fees

More from Pathways & Standards